Karen Blum

Karen Blum

Contributing Writer

Karen Blum is a Baltimore-based freelance health and science writer whose articles have been published in The Baltimore Sun and numerous publications for physicians and other health care professionals. Before freelancing, Blum did media relations work for academic medical centers including The Johns Hopkins Hospital. She earned her bachelor’s and master’s degrees from Northwestern University’s Medill School of Journalism.

  • All
  • Deals
  • Devices and Diagnostics
  • Digital

October 20 2021

Nine Days in September: Three Pharma Plays in Gene Therapy

All eyes turned to gene therapy for nine days in September, as three large pharmaceutical companies—AbbVie, Théa, and Novartis—initiated moves to foster the development of ...
Read More

August 24 2021

Drug Developers Show Renewed Interest in Ocular Allergies

The ocular allergy space has seen some renewed interest lately, with Food and Drug Administration approval of Santen Pharmaceutical’s new drug for vernal keratoconjunctivitis (VKC) ...
Read More

July 20 2021

4DTM Goes It Alone After Roche Pulls Out of Gene Therapy Trials

In 2018, 4D Molecular Therapeutics announced it was expanding its 2015 research agreement with Roche to develop and commercialize multiple ophthalmology products. This summer, things ...
Read More

Heru Closes $30 Million Series A Round

Heru, developer of an artificial intelligence-powered vision diagnostics and augmentation software platform, gave its development program a boost when it closed a Series A financing ...
Read More

June 2 2021

Oxurion Nets a Fresh $36 Million, Names New CEO as Candidates Advance in Pipeline

Oxurion NV, the Brussels-based biopharmaceutical company formerly known as ThromboGenics, entered into a capital commitment agreement of up to $36 million (€30 million) with Negma ...
Read More
Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

August 28 2019

Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

WASHINGTON – With the graying of America and a push to create age-friendly communities and health systems, ophthalmologists and innovators in the field need to ...
Read More
National Vision and Eye Health Surveillance System Gears Up for September Launch

July 23 2019

National Vision and Eye Health Surveillance System Gears Up for September Launch

WASHINGTON – The national Vision and Eye Health Surveillance System (VEHSS) being built by researchers at the University of Chicago’s National Opinion Research Center (NORC) ...
Read More
The Upside of the Optometric Channel

February 27 2019

Corporate Leaders Explain the Upside of the Optometric Channel

NEW ORLEANS – Optometry has become a source of big business for ophthalmic companies over the past decade, with about 40 to 60% of sales ...
Read More
Alcon Executives Lay Out a Road Map for after the Spin-off

December 18 2018

Alcon Executives Lay Out a Road Map for after the Spin-off

With a management team experienced in healthcare and ophthalmology, and market trends like aging increasing the need for ophthalmic care and a rich pipeline of ...
Read More
Seven Steps for Walking the Reimbursement Maze

June 20 2018

Seven Steps for Walking the Reimbursement Maze

WASHINGTON, DC – Getting insurers to reimburse for novel ophthalmic devices and procedures has been getting harder, but by planning early, involving the right employees, ...
Read More
Keeping the MIGS Explosion in Perspective

June 13 2018

Keeping the MIGS Explosion in Perspective

WASHINGTON, DC - When Stanford University ophthalmology professor Kuldev Singh, MD, MPH, underwent medical training 25 years ago, there were maybe five to six non-pharmaceutical ...
Read More
Workshop’s Message: Handle Data with Care

November 8 2017

Workshop’s Message: Handle Data with Care

GAITHERSBURG, MD – Digital Health devices can help detect eye disease in various health-care settings, although ophthalmic practices need to carefully monitor data they generate, ...
Read More